Bullish Stocks Radar: Las Vegas Sands, Celsion Corporation Holdings, CytRx Corporation, Microsoft Corporation


Follow this company

Companies Mentioned

NYSE:LVS / NASDAQ:CLSN / NASDAQ:CYTR / NASDAQ:MSFT
12/13/2013 [ACCESSWIRE]

New York, December 13, 2013 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Las Vegas Sands Corp.(NYSE:LVS), Celsion Corporation(NASDAQ:CLSN), CytRx Corporation(NASDAQ:CYTR), Microsoft Corporation(NASDAQ:MSFT).

Shares of Las Vegas Sands Corp.(NYSE:LVS) are on watch after Sheldon Adelson gives up on his vision of a $30B casino complex in Spain.Plenty of investors have been clamoring for Las Vegas Sands to stick to its strength of producing impressive returns in Asia and avoid the land of +25% unemployment.

Free Urgent Insider Catalyst Report For LVS Available Here:  http://marketbuzzreport.com/index.php?code=LVS (Or Copy and paste the URL into your browser)

Celsion Corporation(NASDAQ:CLSN): "The impressive local response rate seen in these two studies was determined by lesion measurements and digital imaging data," says Dr. Hope Rugo. "Patients are pleased with the local control in the treated areas. I look forward to continuing my involvement in the Phase 2 portion of the DIGNITY study and its future application to clinical development of ThermoDox across different cancers."

Free Urgent Insider Catalyst Report For CLSN Available Here:  http://marketbuzzreport.com/index.php?code=CLSN (Or Copy and paste the URL into your browser)

CytRx Corporation(NASDAQ:CYTR) extended its gains, parlaying an announcement Wednesday into a two-day rally. Shares closed 52.2% higher to $6.12 during Thursday's trading session, adding to an overall 152.1% gain since Wednesday's open.

A rally was sparked after the oncological specialist announced the success of a mid-stage clinical trial of its cancer treatment before the bell Wednesday. The aldoxorubicin study, an experimental treatment targeting soft-tissue sarcomas, was found to have an 80% to 100% success rate in progression-free survival over using chemotherapeutic agent doxorubicin in isolation.

Free Urgent Insider Catalyst Report For CYTR Available Here:  http://marketbuzzreport.com/index.php?code=CYTR (Or Copy and paste the URL into your browser)

In the latest in the guessing game about who will replace Microsoft Corporation(NASDAQ:MSFT) CEO Steve Ballmer, Bloomberg's Dina Bass, Beth Jinks, and Ian King this evening report that Qualcomm (QCOM) chief operating officer Steve Mollenkopf is among candidates currently being considered by the software giant's board, citing multiple unnamed sources.

The article follows a piece last night by AllThingsD's Kara Swisher that stated a number of outside candidates, including Ford's (F) CEO Alan Mulally, as well as well-known internal candidates, had faded recently in terms of their likelihood of getting the job, and that a dark horse candidate from inside Microsoft may be about to emerge.

Free Urgent Insider Catalyst Report For MSFT Available Here:  http://marketbuzzreport.com/index.php?code=MSFT (Or Copy and paste the URL into your browser)  

USMarketBuzz.com  is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an  authorative authentic Google News Site and  Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/  for more details. Get an edge on the market with our Premium News Alerts  that are FREE for a limited time at http://www.USMarketBuzz.com/.

Follow us on Facebook:  https://www.facebook.com/usmarket.buzz.

Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

COMMENTS

Leave a comment...
 * 

Your Name
 *